Suchergebnisse - "Menzies-Gow, Andrew"

PubPharm (12)

1

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL) : a randomised, multicentre, open-label, phase 4 study

enthalten in: Lancet (London, England) | 2024

von Jackson, D. | Heaney, L. | Humbert, M. | +41

ErratumIn: Lancet. 2024 Mar 23;403(10432):1140. - PMID 38521558

2

Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study

enthalten in: The European respiratory journal | 2022

von Menzies-Gow, A. | Gurnell, M. | Heaney, L. | +15

3

A Response to : Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab"

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

CommentOn: Adv Ther. 2022 May;39(5):2065-2084. - PMID 35287231

4

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Jackson, D. | Burhan, H. | Menzies-Gow, A. | +7

5

Clinical Remission in Severe Asthma : A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

CommentIn: Adv Ther. 2022 Aug;39(8):3857-3861. - PMID 35731338

6

Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE) : a multicentre, open-label, single-arm study

enthalten in: The Lancet. Respiratory medicine | 2022

von Menzies-Gow, A. | Gurnell, M. | Heaney, L. | +13

ErratumIn: Lancet Respir Med. 2021 Dec;9(12):e114. - PMID 34695373

7

Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy - Authors' reply

enthalten in: The Lancet. Respiratory medicine | 2022

von Menzies-Gow, A. | Kreindler, J. | Katial, R. | +1

CommentOn: Lancet Respir Med. 2022 Jan;10(1):47-58. - PMID 34619104

8

Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2021

von Bourdin, A. | Shaw, D. | Menzies-Gow, A. | +8

9

Benralizumab : an updated treatment of eosinophilic asthma

enthalten in: Expert review of respiratory medicine | 2020

von Cushen, B. | Menzies-Gow, A.

10

Update in Asthma and Airway Inflammation 2018

enthalten in: American journal of respiratory and critical care medicine | 2019

von Menzies-Gow, A. | McBrien, C. | Baker, J. | +2